ÇATMAZ, Ö. Et Al. 2017. Association Of CYP2C19 Gene rs4244285 Polymorphism With Clinical Cardiovascular Events In Patients Using Clopidogrel. 4 th ESPT Conference. Pharmacogenomics and Personalised Medicine: research progress and clinical implementation , (Catalunya, Spain).

ÇATMAZ, Ö., ÇEVİK, M., GEZER, E., BEZCİ, K., ÜLKER, M., YURDAKUL, S., ... ELÇİOĞLU CENGİZ, B.(2017). Association Of CYP2C19 Gene rs4244285 Polymorphism With Clinical Cardiovascular Events In Patients Using Clopidogrel . 4 th ESPT Conference. Pharmacogenomics and Personalised Medicine: research progress and clinical implementation, Catalunya, Spain

ÇATMAZ, ÖZGE Et Al. "Association Of CYP2C19 Gene rs4244285 Polymorphism With Clinical Cardiovascular Events In Patients Using Clopidogrel," 4 th ESPT Conference. Pharmacogenomics and Personalised Medicine: research progress and clinical implementation, Catalunya, Spain, 2017

ÇATMAZ, ÖZGE Et Al. "Association Of CYP2C19 Gene rs4244285 Polymorphism With Clinical Cardiovascular Events In Patients Using Clopidogrel." 4 th ESPT Conference. Pharmacogenomics and Personalised Medicine: research progress and clinical implementation , Catalunya, Spain, 2017

ÇATMAZ, Ö. Et Al. (2017) . "Association Of CYP2C19 Gene rs4244285 Polymorphism With Clinical Cardiovascular Events In Patients Using Clopidogrel." 4 th ESPT Conference. Pharmacogenomics and Personalised Medicine: research progress and clinical implementation , Catalunya, Spain.

@conferencepaper{conferencepaper, author={ÖZGE ÇATMAZ Et Al. }, title={Association Of CYP2C19 Gene rs4244285 Polymorphism With Clinical Cardiovascular Events In Patients Using Clopidogrel}, congress name={4 th ESPT Conference. Pharmacogenomics and Personalised Medicine: research progress and clinical implementation}, city={Catalunya}, country={Spain}, year={2017}}